Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Nearly two-thirds of America's dogs and cats are overweight or obese1, putting them at increased risk for serious health problems like diabetes, heart disease, and joint issues. To combat this growing ...

If you’ve been on the internet recently, you’ve likely encountered Bryan Johnson’s meticulously optimized, data-driven quest ...

Trauma care has been revolutionized with specialized training programs focused on battlefield injury management. By incorporating laparoscopic and robotic-assisted techniques, military medical teams ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.

Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar, works. A study provided direct evidence in mice that it ...